Trade Summary

2 days ago, Higgins Jack, serving as Chief Scientific Officer at Immunome Inc. (IMNM), sold 9,438 shares at $21.64 per share, for a total transaction value of $204,238.00. Following this transaction, Higgins Jack now holds 25,000 shares of IMNM.

This sale represents a 27.00% decrease in Higgins Jack's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 1 day after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.